Shree Pharma

Twinaqt 50/300 Tablet belongs to a class of drugs called antiretrovirals used to treat HIV infection. Twinaqt 50/300 Tablet helps decrease the chance of developing AIDS (acquired immunodeficiency syndrome). HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help fight infection, making the individual susceptible to other infections or illnesses.

Twinaqt 50/300 Tablet contains Dolutegravir and Lamivudine. Both Dolutegravir and Lamivudine are nucleoside reverse transcriptase inhibitors. Twinaqt 50/300 Tablet works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes necessary for virus reproduction. Together, Twinaqt 50/300 Tablet helps treat HIV infections.

Taffic is used for the treatment of HIV-1 infection in adults and adolescents. It is prescribed as a single-tablet regimen for patients who have no known resistance to integrase inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), or tenofovir.

• Helps manage and treat HIV-1 infection.
• Reduces viral load and increases CD4 cell count.
• Helps prevent HIV progression to AIDS.